Oncolytics Biotech
ONCY
51 hedge funds and large institutions have $756K invested in Oncolytics Biotech in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 3 closing their positions.
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
114% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 7
11% more funds holding
Funds holding: 46 → 51 (+5)
0.11% less ownership
Funds ownership: 1.71% → 1.59% (-0.11%)
37% less capital invested
Capital invested by funds: $1.21M → $756K (-$450K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$37K |
| 2 |
BPWM
Badgley Phelps Wealth Managers
Seattle,
Washington
|
+$29.3K |
| 3 |
BCWM
Ball & Co Wealth Management
Franklin,
Tennessee
|
+$23.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$14.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$11.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$90K |
| 2 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$43.7K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$7.13K |
| 4 |
Morgan Stanley
New York
|
-$4.02K |
| 5 |
BHWM
Beaird Harris Wealth Management
Dallas,
Texas
|
-$754 |
ONCY Hedge Fund Activity: Q1 2025 in Review
51 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q1 2025, worth a combined $756K — down 37% from $1.21M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ONCY positions and 3 closed out — a net gain of 5 holders — while 15 added to existing stakes and 7 trimmed.
The largest buyer was Franklin Resources, adding an estimated $37K. The largest seller was Virtu Financial, exiting entirely with an estimated $90K sold.
- 51 institutional investors held Oncolytics Biotech (ONCY) as of Q1 2025, up from 46 in Q4 2024.
- Funds reported $756K of Oncolytics Biotech stock for Q1 2025, down 37% quarter-over-quarter.
- 8 funds opened new Oncolytics Biotech positions in Q1 2025 and 3 closed out, a net change of +5 holders.
- The largest Oncolytics Biotech buyer in Q1 2025 was Franklin Resources, an estimated $37K added.
- The largest Oncolytics Biotech seller in Q1 2025 was Virtu Financial, an estimated $90K sold.
Based on aggregated 13F filings for Q1 2025.